| 基于因子分析法的我国中药行业上市公司经营绩效评价研究 |
| 投稿时间：2019-10-30 点此下载全文
|
| 引用本文：呼妙炫,王辉龙,都晓春.基于因子分析法的我国中药行业上市公司经营绩效评价研究[J].中国现代中药,2020,22(4):628-635 |
| DOI： |
| 摘要点击次数: 514 |
| 全文下载次数: 237 |
|
|
| 基金项目:吉林省中医药管理局项目（ZYYZC-2018-003） |
|
| 中文摘要:通过对中药行业上市公司经营绩效进行实证分析，提出有利于推动我国中药企业更快、更好发展的对策建议。本研究对我国63家中药行业A股上市公司2018年年报的14个财务指标数据进行因子分析，得出同一公司的不同因子得分不同，盈利能力因子是影响我国中药行业上市公司经营绩效的主导因子，我国中药行业上市公司整体能力尚佳，但还有很大的提升空间。 应从提高自主创新能力、始终严守产品品质、牢固树立品牌优势、打造完整的产业链、推动企业并购整合、推进“互联网+”营销模式等方面着手，提升中药企业整体发展能力。 |
| 中文关键词:因子分析 中药行业 上市公司 经营绩效 |
| |
| A Study on Business Performance Evaluation of Listed Companies in Traditional Chinese Medicine Industry Based on Factor Analysis |
|
|
| Abstract:Through the empirical analysis of the business performance of listed companies in the traditional Chinese medicine industry，put forward countermeasures and suggestions for promoting development of Chinese medicine enterprises faster and better.This paper use factor analysis of 14 financial indicators in the 2018 annual reports of 63 listed Chinese medicine companies.The analysis showed that the scores of different factors of the same company were different.Profitability factor was the leading factor affecting the business performance of listed companies in the traditional Chinese medicine industry.The overall ability of listed companies in the traditional Chinese medicine industry was good，but there was still a lot of room for improvement.In order to improve the overall development ability of traditional Chinese medicine enterprises，we should improve the ability of independent innovation，always adhere to product quality，firmly establish brand advantages，build a complete industrial chain，promote the integration of enterprise mergers and acquisitions，and promote the ″Internet+″ marketing model. |
| keywords:factor analysis traditional Chinese medicine industry listed company business performance |
|
查看全文
查看/发表评论 下载PDF阅读器 |
